We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Keytruda

News List

BMS, Ono Pharma and Merck resolve PD-1 antibody patent litigation cphi-online
January 24, 2017
Merck to pay BMS and Ono royalties on global sales of Keytruda through 2026, and lump-sum payment of $625 million.
Bristol-Myers Squibb, Ono settle patent lawsuit with Merck & Co. regarding Keytruda firstwordpharma
January 22, 2017
Bristol-Myers Squibb and Ono Pharmaceutical on Friday announced that they have reached an agreement with Merck & Co. to settle patent-infringement litigation regarding the latter's PD-1 antibody Keytruda (pembrolizumab).
Investigators line up Keytruda, cancer vax combo trial in glioblastoma fiercepharma
January 19, 2017
In what could see another use added to Merck & Co.’s immuno-oncology star Keytruda, the checkpoint inhibitor is set for testing in glioblastoma as part of a combo with Agenus’ cancer vaccine Prophage.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 16 17 Next page